Molecular Partners AG revenue for the last year amounted to 7.74 M USD, the most of which — 7.83 M USD — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 198.52 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought Molecular Partners AG 7.83 M USD, and the year before that — 188.41 M USD.